Haleon (HLN) Interest & Investment Income (2021 - 2025)
Haleon's (HLN) quarterly Interest & Investment Income came in at $63.0 million in Q4 2025, up 33.52% on a QoQ basis from $47.2 million in Q4 2023.
Haleon (HLN) Interest & Investment Income (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Interest & Investment Income data on file, last reported at $63.0 million in Q4 2025.
- Quarterly Interest & Investment Income changed N/A year-over-year to $63.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $157.4 million (changed N/A YoY) and the FY2025 annual result came in at $103.8 million, down 1.02% from the prior year.
- Interest & Investment Income climbed to $63.0 million in Q4 2025, from $47.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $63.0 million in Q4 2025 to a low of $12.2 million in Q2 2023.
- A 4-year average of $39.8 million and a median of $47.2 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 187.81% — and 2023, when it slipped 6.49%.
- Tracing HLN's Interest & Investment Income over 4 years: stood at $17.5 million in 2021, then surged by 187.81% to $50.4 million in 2022, then decreased by 6.49% to $47.2 million in 2023, then soared by 33.52% to $63.0 million in 2025.
- The last three Interest & Investment Income figures came in at $63.0 million (Q4 2025), $47.2 million (Q4 2023), and $35.0 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 5.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.97 Mn |
| Dec 31, 2023 | 47.16 Mn |
| Jun 30, 2023 | 35.04 Mn |
| May 3, 2023 | 12.23 Mn |
| Dec 31, 2022 | 50.44 Mn |
| Sep 20, 2022 | 52.95 Mn |
| Dec 31, 2021 | 17.52 Mn |